MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-08-0061985
Maggenome Technologies Private Limited - life sciences in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹86.17 Lakh
▼ 6% YoY
Net loss · FY 2025
₹2.64 Cr
Net margin -306.9%
EBITDA · FY 2025
-₹2.38 Cr
EBITDA margin -276.7%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹4.44 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
30
Provident fund records
Directors on board
3
As per MCA filings
About Maggenome Technologies Private Limited
Data last updated:
Maggenome Technologies Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 25 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2015PTC038529. Its GSTIN is 32AAJCM7709G1ZG (Kerala). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹4.44 Lakh. It is led by directors including Balamaniamma Madathinkal Raghavan Nair and Chaniyilparampu Nanappan Ramchand.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at VII 431 – C1 Narayana Building Thazhavaram Lane Kakkanad, Ernakulam, Kerala, India – 682030.
As per the financials filed for FY 2025, the company reported a revenue of ₹86.17 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹2.64 Cr (net margin -306.9%) and EBITDA of -₹2.38 Cr (EBITDA margin -276.7%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 6% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: MagGenome. The company has 5 deals on record (2 rights issues, 2 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹9.34 Cr; the latest was in April 2019. Its 10 peer companies in the Biotechnology industry (Biotechnology) are compared by revenue, 5 larger and 5 smaller; the largest is Oxyflora Biotech Private Limited with revenue of ₹89.36 Lakh.
Maggenome Technologies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0061985). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maggenome.com.
Company Details of Maggenome Technologies Private Limited
CIN U74999KL2015PTC038529
Registration Number 038529
Incorporation Date 25 May 2015
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-08-0061985
Key People
Balamaniamma Madathinkal Raghavan Nair Director Chaniyilparampu Nanappan Ramchand Director Jegatheesan Mohan Director Recognitions & Rankings of Maggenome Technologies
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressVII 431 – C1 Narayana Building Thazhavaram Lane Kakkanad, Ernakulam, Kerala, India – 682030
- IndustryLife Sciences, Biotechnology
Comprehensive company report
Maggenome Technologies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Maggenome Technologies Private Limited
Maggenome Technologies operates one associated brand: MagGenome. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nucleic acid extraction kits are developed using nanoparticle technology. | maggenome.com |
Business Activity of Maggenome Technologies Private Limited
The main business activity of Maggenome Technologies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maggenome Technologies Private Limited FY 2024 filings available
Maggenome Technologies Private Limited reported revenue of ₹86.17 Lakh (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹86.17 Lakh ▼ 6%
Net loss · FY 2025
₹2.64 Cr margin -306.9%
EBITDA · FY 2025
-₹2.38 Cr margin -276.7%
Compounded Annual Growth Rate (CAGR) of Maggenome Technologies Private Limited
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 65%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 34%
5 years · compounded
▼ 7%
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maggenome Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.38 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.64 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maggenome Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -276.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -306.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maggenome Technologies are in the company report.
Premium access
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maggenome Technologies Private Limited
Maggenome Technologies has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balamaniamma Madathinkal Raghavan Nair Also directs: Nextgen Science Media Private Limited, Thinkbio AI India Private Limited, Simisco Biologics Private Limited and 5 more | Director | 25 May 2015 | 11 Years 4 Months | Current |
| Chaniyilparampu Nanappan Ramchand Also directs: Simazz Therapeutics Private Limited, Apamar Biotech Private Limited, Medscape Pharma Private Limited and 1 more | Director | 15 Jun 2023 | 3 Years 4 Months | Current |
| Jegatheesan Mohan | Director | 20 Aug 2025 | 1 Years 2 Months | Current |
Peer Comparison of Maggenome Technologies Private Limited
Maggenome Technologies Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oxyflora Biotech Private Limited | ₹89.36 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Delhi, India |
| Dandu Biosciences Private Limited | ₹89.14 Lakh (FY 2025) | •••• | •••• | 25573.0% | •••• | Hyderabad, Telangana, India |
| Progressive Analytical & Research Laboratory Private Limited | ₹89.1 Lakh (FY 2024) | •••• | •••• | 164.0% | •••• | Dehradun, Uttarakhand, India |
| Genomatics Private Limited | ₹88.81 Lakh (FY 2025) | •••• | •••• | 107.0% | •••• | Coimbatore, Tamil Nadu, India |
| S V Monco Biotech Private Limited | ₹87.5 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Maggenome Technologies Private Limited this company | ₹86.17 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Ernakulam, Kerala, India |
| Eurofins Advinus Lifesciences Private Limited | ₹85.74 Lakh (FY 2024) | •••• | •••• | -77.0% | •••• | Bangalore, Karnataka, India |
| Genomic Valley Biotech Limited Listed | ₹84.84 Lakh (FY 2025) | •••• | •••• | 409.0% | •••• | Jhajjar, Haryana, India |
| Applied Genomics Private Limited | ₹83.6 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Coimbatore, Tamil Nadu, India |
| Kahan Biotech Private Limited | ₹83.56 Lakh (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Crisprbits Private Limited | ₹83.35 Lakh (FY 2025) | •••• | •••• | 249.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Maggenome Technologies by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maggenome Technologies Private Limited
Maggenome Technologies Private Limited is audited by Varma & Varma for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Varma & Varma | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maggenome Technologies Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maggenome Technologies Private Limited
Maggenome Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Maggenome Technologies Private Limited
Maggenome Technologies Private Limited has 5 deals on record (2 rights issues, 2 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹9.34 Cr; the latest was in April 2019.
Total deals
5
Rights issues
2
Convertible or debt financings
2
Secondary share transfer
1
Disclosed funding
₹9.34 Cr
Deals on record (3 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2017 | Secondary share transfer | Undisclosed | Buyer: Emerge Ventures Seller: Sci Ventures INC |
| Jul 2016 | Rights issue | ₹65.5 Lakh | Investors: Emerge Ventures |
| Jan 2016 | Rights issue | ₹63.6 Lakh | Investors: Emerge Ventures, Sci Ventures INC |
Premium access
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Maggenome Technologies Private Limited
Maggenome Technologies Private Limited has a workforce of 30 employees as of Apr 06, 2024.
Employee count
30
Active EPFO establishments
1
Employee growth
-25%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maggenome Technologies Private Limited
Maggenome Technologies Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Jegatheesan Mohan ceased to be Additional Director on 29 Sep 2025.
Ceased
Jegatheesan Mohan ceased to be Additional Director.
Ceased
Sreedhar Santhosh ceased to be Director.
Ceased
Arumugam Sivaraman ceased to be Director.
Appointed
Jegatheesan Mohan was appointed as Director.
AGM
Maggenome Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Surajit Chakrabartty ceased to be Additional Director.
Filing
Maggenome Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
Appointed
Chaniyilparampu Nanappan Ramchand was appointed as Director.
Appointed
Balamaniamma Madathinkal Raghavan Nair was appointed as Director.
Incorporation
25 May 2015
Maggenome Technologies Private Limited was registered on 25 May 2015 with Roc Ernakulam & aged 11 years 4 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Maggenome Technologies Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maggenome Technologies Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maggenome Technologies Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maggenome Technologies Private Limited
Maggenome Technologies has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAJCM7709G1ZG | Kerala | Active | 01 Jul 2017 |
| 33AAJCM7709G1ZE | Tamil Nadu | Active | 09 Mar 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maggenome Technologies Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Maggenome Technologies Private Limited
Frequently Asked Questions about Maggenome Technologies Private Limited
Maggenome Technologies is an active private limited company based in Ernakulam, Kerala, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 25 May 2015 (11+ years old) and is registered under CIN U74999KL2015PTC038529.
Maggenome Technologies reported revenue of ₹86.17 Lakh for FY 2025 (down 6% YoY).
Maggenome Technologies has 3 current directors:
- Balamaniamma Madathinkal Raghavan Nair - Director
- Chaniyilparampu Nanappan Ramchand - Director
- Jegatheesan Mohan - Director
Maggenome Technologies reported a net loss of ₹2.64 Cr (net margin -306.9%) and EBITDA of -₹2.38 Cr (EBITDA margin -276.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maggenome Technologies is -65% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maggenome Technologies is 32AAJCM7709G1ZG, registered in Kerala. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AAJCM7709G1ZE (Tamil Nadu).
The CIN (Corporate Identification Number) of Maggenome Technologies is U74999KL2015PTC038529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maggenome Technologies was incorporated on 25 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ernakulam.
Maggenome Technologies has 5 deals on record (2 rights issues, 2 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹9.34 Cr; the latest was in April 2019.
The peers of Maggenome Technologies by revenue are Oxyflora Biotech Private Limited, Dandu Biosciences Private Limited, Progressive Analytical & Research Laboratory Private Limited, Genomatics Private Limited, S V Monco Biotech Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Jegatheesan Mohan ceased to be Additional Director on 29 Sep 2025. Sreedhar Santhosh ceased to be Director on 20 Sep 2025. Arumugam Sivaraman ceased to be Director on 20 Aug 2025. Maggenome Technologies has 7 board changes on record in total.